Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
SN

Smith & Nephew plc

SNLSEUnited KingdomHealthcareMedical DevicesFTSE 100

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It…more

P/E18.11xP/B2.21xROIC8.3%Dividend yield2.9%
£8.49B
Market Cap
EV: £11.65B
MOM2
QUAL7
VAL8
RSK3
SN
£8.49B
Market Cap · EV £11.65B

Smith & Nephew plc

MOM2
QUAL7
VAL8
RSK3

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It…more

Latest RNS from Smith & Nephew plc

Analyst consensus: Hold

As of 6 Oct 2026, 18 analysts rate Smith & Nephew plc a Hold, with 22% buy ratings and a mean price target of 1,277p (range 1,068p–1,568p), +25% vs the current price.

Strong buy: 1Buy: 3Hold: 13Sell: 0Strong sell: 1

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 1,604p against a current price of 1,010p (+59%), based on EV/EBITDA.

More Healthcare companies